CSRWire News

Subscribe to CSRWire News feed
CSRwire Press Releases, Events and Reports
Updated: 2 hours 15 min ago

Aaron’s Inc. (AAN) Recommended for Deletion from the Calvert Social Index

Tue, 04/08/2014 - 5:04pm

Calvert’s Sustainability Research Department has submitted the following recommendation regarding action within the Calvert Social Index®. If approved, the recommendation will be effective when the Calvert Social Index Committee convenes its quarterly meeting in June.

ADDITIONS:

None.

DELETIONS:

Aaron’s Inc. (NYSE: AAN), a company in the Calvert Social Index, has recently been reviewed and no longer meets the Index’s standards for governance and ethics.  If approved, the deletion will take place in June 2014.

What is the Calvert Social Index?

Calvert, a leader in sustainable and responsible investing, has created the Calvert Social Index, a broad-based, rigorously constructed benchmark for measuring the performance of US-based sustainable and responsible companies.

How is the Calvert Social Index constructed?

Calvert starts by taking the 1,000 largest companies in the US, based on total market capitalization, included in the Dow Jones Total Market Index (the “Dow Jones TMI”).  The Dow Jones TMI represents the top 95% of U.S. companies based on float-adjusted market capitalization, excluding the very smallest and least-liquid stocks.  Calvert's Sustainability Research Department then analyzes each company. A sustainability audit is conducted in the following areas: governance and ethics; environment; workplace; product safety and impact; community relations; international operations and human rights; and indigenous peoples’ rights. The stocks that meet all of the Index’s sustainable and responsible criteria make up the Calvert Social Index.

Effective April 30, 2014, all corporate actions and changes within the Calvert Social Index will be made public only at Calvert.comwww.calvert.com/sri-index.html

Calvert Investment Management, Inc., 4550 Montgomery Avenue, Suite 1000N, Bethesda, MD 20814 (4/14) #13926

Global Advanced Certified Sustainability (CSR) Practitioner Training (IEMA Approved)

Tue, 04/08/2014 - 1:59pm

Has vacation on a Greek Island always been your dream?

Are you interested in getting a formal training on CSR?

CSE invites you to combine both this summer in one of the most beautiful Greek Islands!

CSE courses are accredited and approved by IEMA (Institute of Environmental Management and Assessment), the leading international membership-based organization for Sustainability Professionals with more than 15,000 members based in 83 countries.

Key Issues to be covered:
This challenging 2-day training program enables participants to acquire the skills and competencies required for the effective use of the GRI Framework, GRI reports and publication of CSR/ Sustainability Reporting in alignment with the new GRI G4 Guidelines.

The training provides insight on the conceptual introduction and preparation of the GRI reporting process, covers all the issues related to the dialogue with stakeholders and credibility of the reporting process, defines the content of the report and the monitoring process and explains in detail the preparation and communication of the final report.

The Certified Training Program aims to disseminate knowledge on sustainability reporting around the world. It has been developed especially to help report makers and users to more effectively use the GRI Framework and utilse GRI reports. Upon successful completion of the course, trainees are able to apply their knowledge in all levels of CSR and Sustainability Reporting according to GRI G4 guidelines and will receive course certificates directly from GRI confirming their acquired knowledge on Reporting.

Modules:
1. Sustainability (CSR) and the Business Case for Adoption
2. Current Global & Local Legislation for CSR and GHG Emissions
3. Sustainability (CSR) Strategy and Related Global Standards and Guidelines
4. The Importance of Sustainability (CSR) in Supply Chain and Carbon Footprint Reduction
5. Sustainability (CSR) and Integrated Reporting based on GRI and IIRC Guidelines
6. External Assurance and How to Communicate and Gain Credibility in Your Report
7. The Role of the Sustainability (CSR) Practitioner / Future Trends and Practitioner Assignment

Who should attend:
• CSR Professionals
• Public Relations
• Communication and Marketing Managers
• Human Resources Managers
• Sustainability and Environmental professionals
• General Managers

New Model Needed in Diabetes Care

Tue, 04/08/2014 - 1:59pm

Participants at the 5th International DAWN™ Summit (Diabetes Attitudes Wishes and Needs) today pledged to work together to make person-centred diabetes care a reality for the 382 million people living with diabetes around the world.[i]

While it is widely acknowledged that optimal diabetes care is best achieved by collaboration between people with diabetes, their families and healthcare teams, acute care models for diabetes treatment remain commonplace. But with 592 million people estimated to have diabetes by 2035,1 placing people at the centre of a healthcare system – which is designed around the person with diabetes and takes a holistic view of that individual in order for them to achieve a better quality of life - has become an urgent global priority.

Hosted by the International Diabetes Federation (IDF), the International Alliance of Patients’ Organizations (IAPO) and the Steno Diabetes Center and with support from Novo Nordisk, the DAWN™ Summit brought together over 200 leading experts, policymakers, researchers, clinicians and patient advocates from more than 30 countries to discuss policies, strategies, tools and best practices needed to enable partnership action to achieve this goal.

Working together across all stakeholder groups, some of the key priorities were:

  • Strengthen the voice of people with diabetes and their families locally and globally
  • Build and nurture trusting relationships and communication among all stakeholder groups, including people with diabetes to drive positive change
  • Ensure availability of whole-person centred and participatory self-management education for people with diabetes as well as their families
  • Enact the rights of people with diabetes and their families to have a supportive and non-discriminatory environment.

President of the IDF and Chair of the summit, Sir Michael Hirst, explains: “The recently published results of the global DAWN2™ study show that people with diabetes need education and support in order to take a central role in their own care. To honour the pledge made today it is therefore our duty to engage with policymakers and healthcare providers around the world to make a lasting difference to the delivery of education, support and care for people with diabetes. Person-centred diabetes care can thereby be made a reality, thus improving the lives of millions of people globally.”

During the two-day summit, participants focused on defining actionable strategies to advance access to person-centred diabetes care – which goes beyond the delivery of care by healthcare professionals to encompass employers and society at large – concentrating on the practical steps that each country must take and outlining targets and indicators for measuring progress over time at national and global levels.

Scientific outcomes of the 5th International DAWN™ Summit will be published by the summit partner organisations in the following months.

About DAWN2™
DAWN2™ is a global Novo Nordisk initiative conducted in collaboration with the IDF, the International Alliance of Patients’ Organizations (IAPO), the Steno Diabetes Center and a range of other national, regional and global partners. The DAWN2™ results highlight opportunities for improving diabetes care, education and community support by putting people with diabetes and their families centre stage. The DAWN2™ study will be used internationally and nationally to facilitate dialogue among patient organisations, healthcare professionals and other key stakeholders to develop action plans for improvement of the lives of people with diabetes. Further information is available at www.dawnstudy.com.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 38,000 employees in 75 countries, and markets its products in more than 180 countries.

For more information, visit novonordisk.com.

Further information

Media: 

 

 

Charlotte Zarp-Andersson

+45 3079 7603

czpa@novonordisk.com

Ken Inchausti (US)

+1 609 514 8316

kiau@novonordisk.com

 

 

 

Investors: 

 

 

Kasper Roseeuw Poulsen

+45 3079 4303

krop@novonordisk.com

Frank Daniel Mersebach

Daniel Bohsen

+45 3079 0604

+45 3079 6376

fdni@novonordisk.com

dabo@novonordisk.com

Lars Borup Jacobsen

+45 3075 3479

lbpj@novonordisk.com

Jannick Lindegaard (US)

+1 609 235 8567

jlis@novonordisk.com

 

[i] IDF Diabetes Atlas. International Diabetes Federation 2013. 6th edition.

The UPS Foundation Invests More Than $9 Million in Grants and Support for Global Community Safety

Tue, 04/08/2014 - 1:59pm

Today, The UPS Foundation, the philanthropic arm of UPS (NYSE: UPS), announced it will donate more than $9 million toward community safety initiatives focused on enhancing disaster response, recovery, and emergency preparedness through enhanced technology infrastructure and road safety initiatives. To underscore the importance of humanitarian supply chain capabilities, UPS will deploy UPS Relief LinkTM, humanitarian supply chain solutions that strengthen the tracking of critical relief supplies. UPS is working with the United Nations High Commissioner for Refugees (UNHCR) to provide better visibility of the journey of urgently needed items through the last mile of delivery to refugees.

Community Safety is one of four pillars The UPS Foundation lends both its financial support and logistics expertise to serve communities worldwide. Under this pillar, The UPS Foundation addresses humanitarian relief initiatives through disaster preparedness, as well as relief and recovery efforts.

In addition to making the UPS Relief Link program more widely available, The UPS Foundation is also awarding $1 million to CARE, a leading humanitarian organization fighting global poverty, to implement the Aidmatrix supply chain management platform, called SCM4Good. These technology tools include commodity tracking, asset management and fleet optimization modules to increase the visibility of global inventories, thus speeding relief and recovery efforts.  

“Each year, millions of people are impacted by natural disasters all over the world,” said Eduardo Martinez, president of The UPS Foundation. “We believe we can help reduce the subsequent human suffering by collaborating with our partners and to help communities better prepare for the unexpected. Our strong expertise in logistics and supply chain management demonstrates the value we place on equipping individuals and businesses with the skills, information and resources to ensure communities are better prepared.”

Being a leader in global logistics services begins with the road. Road safety is also part of the Community Safety pillar, where UPS leverages its expertise in safe driving to develop robust educational programs that pass on this expertise to young drivers.

As road conditions vary around the globe, particularly in developing nations, The UPS Foundation devotes many of its road safety grants to nonprofit organizations in international regions that may have unsafe road infrastructures. From Latin America to Southeast Asia, The UPS Foundation’s contributions support helmet protection for drivers on motorized vehicles, as well as training young drivers how to navigate dangerous road conditions and tips for traveling with young passengers onboard.

“The UPS Foundation is heavily invested in ensuring drivers are educated about safe driving practices in their region,” Martinez continued. “For more than 100 years, we’ve been committed to safe driving and will continue to implement innovative and interactive programs that bring UPS’s road safety knowledge to drivers around the world.”

The UPS Foundation’s community safety grants will support several organizations that provide humanitarian relief, totaling more than $6.6 million and include:

  • The Aidmatrix Foundation, Good360, UNHCR, UNICEF and the World Food Programme will receive grants that benefit technology and supply chain initiatives to improve back-end processes and tracking behind humanitarian relief efforts.
  • The American Red Cross, CARE, MedShare, National Voluntary Organizations Active in Disaster, Operation Hope, Salvation Army and St. Bernard Project will benefit from ongoing support for disaster relief efforts, including providing food, shelter and other essential recovery needs.
  • Grants for ongoing emergency preparedness and training programs for American families and businesses will be awarded to the Advertising Council and Safe America Foundation.
  • In order to collectively address global challenges, the following organizations will receive grants to strengthen community resilience through greater public/private partnerships. They include InterAction, the United Nations Office for the Coordination of Humanitarian Affairs and the U.S. Chamber of Commerce Foundation Corporate Citizenship Center.
  • The Georgia Tech Foundation will receive scholarship dollars for students in its International Humanitarian Logistics program.

Other organizations that are recipients of The UPS Foundation's community safety grants, for the purpose of championing road safety, total more than $2.4 million and include:

  • The Boys & Girls Club of Canada, Johanniter-Unfall-Hilfe e.V, Hands on Shanghai and UK Youth will receive grants to expand the UPS Road Code safety program in Canada, Germany, China and the UK.
  • The Asia Injury Prevention Foundation will receive a grant for its Helmets for Kids program in Cambodia, Thailand and Vietnam.
  • Grants for ongoing emergency preparedness training and safe driving educational programs will be awarded to Citizenship Education Fund, FIA Foundation and Fundaciόn Gonzalo Rodrίguez.

For more information about UPS’s corporate giving, please visit UPS.com/Foundation.

About The UPS Foundation
UPS (NYSE: UPS) is a global leader in logistics, offering a broad range of solutions including the transportation of packages and freight; the facilitation of international trade, and the deployment of advanced technology to more efficiently manage the world of business. Since its founding in 1907, UPS has built a legacy as a caring and responsible corporate citizen, supporting programs that provide long-term solutions to community needs. Founded in 1951, The UPS Foundation is responsible for facilitating community involvement to local, national, and global communities. In 2013, UPS and its employees, active and retired, invested more than $102 million in charitable giving around the world. The UPS Foundation can be found on the web at UPS.com/Foundation.  To get UPS news direct, visit pressroom.ups.com/RSS

Charitable Giving Cools as More Consumers Turn to Responsible Shopping as Way to "Give Back"

Tue, 04/08/2014 - 10:59am

Consumers are choosing cause-based brands over charitable giving when they look to give back, according to a second annual benchmark study by Good.Must.Grow. (GmG), a socially responsible marketing consultancy.

In a poll of 1,010 Americans, 30 percent of consumers said they plan to increase the amount of goods and/or services they buy from socially responsible companies in the coming year, a modest uptick from 29 percent in 2013. Meanwhile, only 18 percent plan to increase charitable giving in 2014, a decline from 21 percent in 2013.

One in five consumers (19%) said they prefer to “give back” by purchasing socially responsible products, while another 39 percent preferred to split their giving between charities and cause-based brands. When asked to select reasons for preferring socially responsible purchases over charitable contributions, more than half (52%) said it was an easier way for them to give back consistently. Just under half (48%) also reported it was a more effective way to support positive change or make a difference.

“The line between charity and commerce is blurring for many consumers, thanks to increasing opportunities for socially responsible spending,” said Heath Shackleford, founder of Good.Must.Grow. “As a result, forward-thinking causes should be evaluating whether they can diversify their organizations so they aren’t solely dependent upon grants and donations.”

All signs point to continued momentum for brands that are centered on social impact. In addition to the planned increase in responsible spending, 29 percent of those surveyed said they avoided buying products from a company specifically because it wasn’t socially responsible. This is up from 25 percent who reported the same activity in 2013.

The growth of conscious consumerism could be further amplified if the “good choice” was a little easier for shoppers to make. While 62 percent said buying goods or services from socially responsible companies was important, only 33 percent actively sought out such companies. When asked what prevented them from buying more socially responsible products in 2013, almost half (45%) cited that knowledge was a key issue, meaning they did not know how to find socially responsible products, or which products were actually socially responsible. This outranked availability, price, quality, selection and trust as potential roadblocks to conscious consumption.

“The Good.Must.Grow. research shows that we need to be doing even more to celebrate and promote people who are using business as a force for good,” said Jay Coen Gilbert, co-founder of B Lab, the nonprofit organization that certifies B Corporations and governs the B Impact Assessment. “As a community, we have to speak with one, unified voice to make socially responsible products and services easier for consumers to identify and support.”

Conscious Consumer Spending Index On the Rise
Overall, GmG saw the Conscious Consumer Spending Index (#CCSIndex) climb slightly to 68 on a 100-point scale, up from 65 in 2013. The #CCSIndex is a score calculated by evaluating the importance consumers place on purchasing from socially responsible companies, actions taken to support such products and services, and future intent to increase the amount they spend with responsible organizations.

But as in last year’s report, even the most altruistic consumers are susceptible to a good deal. More than half (52%) said they would be more likely to purchase a product from a store that offered them a “buy one get one” special, versus a store making a donation to charity on their behalf (22%) or a store giving away the same product they purchased to those in need (18%).

Other findings:

  • In 2013, 29 percent of consumers planned to increase their socially responsible spending. In 2014, 22 percent reported increased spending in this area, which means 75 percent followed through on their intentions to do more good.
  • The #CCSIndex also measured activity across four regions (Northeast, Midwest, South and West). The Midwest led the way with an index score of 73, while the South finished last with a score of 62.
  • An overwhelming majority (90%) of consumers reported “being green” in the past 12 months, while 79 percent reported reducing consumption (gas, energy, overall purchasing)
  • Fewer consumers are trusting traditional advertising as a source for determining whether a company is socially responsible. In 2013, 29 percent cited advertising as an evaluation tool, while in 2014, that number has dropped to 22 percent.
  • When evaluating whether or not a company is socially responsible, how the company treats its employees remains the most important factor with 45 percent rating it as very important. This was followed closely by the company's impact on the environment (40%).
  • When asked which entity was most effective at making positive changes in society, 73 said nonprofits and 72 percent rated individuals as being very or somewhat effective. Social enterprises (56%) edged major corporations (55%) and outpaced local government (44%) and the federal government (36%). Joint efforts between government, corporations and nonprofits came in at 60 percent.

About the Survey
This study was conducted in partnership with Supportive Research Solutions and What They Think Research. Sampling was provided by ResearchNow. Data was collected February 20 – May 10, 2014. In total, 1,010 Americans were surveyed. Margin of error is +/-3%. For more information on the Conscious Consumer Spending Index, please visit www.goodmustgrow.com/ccsindex

About Good.Must.Grow.
Good.Must.Grow. provides strategic marketing support for socially responsible businesses, nonprofit causes and organizations that are focused on health + wellness. We want to be part of a revolution that drives societal change by sparking increased charitable giving and community involvement as well as unprecedented levels of corporate social responsibility. Proud to be a Certified B Corp. See how we’re #GrowingGood at http://www.goodmustgrow.com. 

CA Technologies Goes Green With Annual Earth Day Activities

Tue, 04/08/2014 - 10:59am

CA Technologies (NASDAQ: CA) today announced its annual Green Week of worldwide employee volunteer activities in celebration of Earth Day. Currently in its seventh year, Green Week promotes environmental awareness and supports the company’s sustainability efforts. As part of the program, CA Technologies employees will give time during their work day to nonprofit organizations, and participate in activities like beach clean-ups, tree plantings, trail maintenance and more.

Employee-driven projects will take place throughout the U.S. in locations including Atlanta, GA; Austin, TX; Bellevue, WA, Cary, NC; East Windsor, CT; Ewing, NJ; Framingham, MA; Ft Collins, CO; Herndon, VA; Islandia, NY; Lisle, IL; New York City, NY; Pittsburgh, PA; Plano, TX; Portsmouth, NH; Santa Clara, CA; Southfield, MI; and Tampa, FL and internationally in countries including Argentina, Australia, Chile, China, Colombia, Czech Republic, India, the Netherlands, Singapore, Spain, and the United Kingdom.

“Giving back to the communities where our employees live and work is an important part of our company culture,” said Erica Christensen, vice president, Corporate Social Responsibility, CA Technologies. “Whether it's planting trees, revitalizing distressed neighborhoods or cleaning local beaches and parks, CA employees will again come together and work to strengthen the communities where we do business.”

“Ecology Action’s mission is to create a healthier environment through resource recovery operations, Brownfield remediation and zero waste initiatives.” said Brent Perdue, Co-Director, Ecology Action in Austin. “Our recycling center reduces waste that is bound for local landfills. Together, with help from CA Technologies volunteers, we can help to create a more sustainable environment for everyone.”

“A great deal of garbage ends up in our rivers every day, which not only creates an eyesore, but threatens the lives of species that depend on this habitat,” said David Thomas, Volunteer Coordinator, Chattahoochee River National Recreation Area in Atlanta. “Once again, CA Technologies employees are dedicating their time to preserving our natural resources.  With their assistance, we hope to ensure clean waterways in our park -- for all to enjoy.”

“The volunteer efforts made by CA Technologies employees are crucial in helping to protect Australia’s bushland areas,” said Sandra Payne, Bushcare Volunteer Coordinator, City of Ryde. “Planting native vegetation as well as the removal of invasive species will encourage regeneration of the bush lands and ultimately assist in maintaining our valued natural resources.”

Conducting business in a way that advances sustainability is a top priority for CA Technologies. Highlights of the company’s sustainability efforts include:

  • Active employee Green Teams—representing more than half of the company’s workforce—committed to reducing natural resource consumption at CA Technologies offices around the world.
  • A commitment to reducing the company’s greenhouse gas emissions.
  • Company products and solutions that improve data center efficiency for CA Technologies and its customers.
  • Purchasing electricity from renewable resources.
  • Building approximately 330,000 square feet of company office space that is LEED-registered or under a green lease.
  • Being recognized as a sustainability leader by the Dow Jones Sustainability Index, the UN Global Compact 100 Stock Index, the FTSE4Good Index Series, Maplecroft Climate Innovation Index and on Newsweek’s Green Rankings.

About CA Together
CA Technologies is a global corporation with a local commitment. The company works to improve the quality of life in communities where its employees live and work worldwide and is fully committed to advancing social, environmental and economic sustainability. CA Together, the company’s global Corporate Social Responsibility program, is driven by the core philanthropic focus of improving the lives of underserved children and communities around the world. CA Technologies does this by supporting organizations, programs and initiatives that enrich the lives and well-being of others in focus areas including education and technology, health and human services, and the advancement of women in IT. CA Together activities encompass employee volunteerism and matching gifts; in-kind donations of CA Technologies products and services; and wide-ranging partnerships and philanthropic support to community organizations worldwide. 

About CA Technologies
CA Technologies (NASDAQ: CA) provides IT management solutions that help customers manage and secure complex IT environments to support agile business services. Organizations leverage CA Technologies software and SaaS solutions to accelerate innovation, transform infrastructure and secure data and identities, from the data center to the cloud. Learn more about CA Technologies at www.ca.com.

Follow CA Technologies 

Legal Notices

Copyright © 2014 CA. All Rights Reserved. One CA Plaza, Islandia, N.Y. 11749. All other trademarks, trade names, service marks, and logos referenced herein belong to their respective companies.

The Aspen Institute Announces Second Class of New Voices Fellows

Tue, 04/08/2014 - 10:59am

The Aspen Institute announced today the second class of the New Voices Fellowship, a groundbreaking program designed to amplify the voices of experts from the developing world and bring their experiences to discussions of global development. The 2014-2015 fellows come from 12 countries across three continents: Ethiopia, Ghana, Haiti, Indonesia, India, Kenya, Nigeria, South Africa, Tanzania, Uganda, Zambia and Zimbabwe. These fellows will undertake a program of intensive media training and mentorship to help them reach a broader global audience through both traditional and new media and speaking engagements.

This year’s fellows include: advocates working in schools and through social media on sustainable, locally driven entrepreneurship; an outspoken leader for the rights of gay, lesbian, transgender and other sexual minorities across Africa; medical professionals advancing reproductive rights of women and girls, and combatting preventable and chronic diseases in countries from Haiti to Ethiopia, Nigeria and Tanzania; business leaders creating mobile devices to improve health care in all settings; advocates for good governance and food security; and a defender of Indonesian coral reefs.

“Far too often, the leaders who are having the biggest impacts on the ground in the developing world are not those that are visible outside of their home countries. We want to change that to ensure that these leaders can speak for themselves to global media and ultimately international policymakers,” said Peggy Clark, executive director of Aspen Global Health and Development, and vice president of policy programs at the Aspen Institute.

“The New Voices Fellowship is a vehicle to help share the most critical and impactful programs, solutions and innovations with other leaders around the world,” Clark added.

Supported by the Bill & Melinda Gates Foundation, the New Voices Fellowship was established in 2013 to bring the essential perspectives of committed development experts from Africa and other parts of the developing world into the global development debate.

“This year’s class of fellows is an impressive crowd that will match the incredible work we saw in the first class of New Voices,” said Andrew Quinn, director of the fellowship at Aspen. “What makes these leaders so inspiring is their proven track record of working on the ground to improve lives both individually and collectively. They are showing us the next big ideas in development.”

In addition to personal coaching on creating a dynamic platform to get their messages across, Fellows will receive introductions to select media outlets, serve as sources for journalists, and speak at high-profile conferences throughout the fellowship period. The group held its first workshop in Johannesburg in March, with another group meeting later in the year.

During the program’s first year, New Voices fellows were featured more than 76 times in media outlets and speaking opportunities, including op-ed articles in CNN, Al Jazeera and the New York Times, interviews for NPR and the BBC, and a speech on the TED main stage.

Application to the fellowship is by nomination only, and nominations will open in September 2014 for the next class. The 2015 New Voices fellows will be announced in early 2015.

For more about the New Voices Fellowship and further information about this year’s fellows, please visit www.aspennewvoices.org or email aspennewvoices@aspeninst.org. Follow all the fellows and the fellowship on Twitter at @aspennewvoices.

Editor’s note: Photos and a video of the 2014 New Voices Fellows are available upon request. 

The 2014 New Voices Fellows are:

Adebisi Alimi

Founder, Bisi Alimi Consultancy, Nigeria, @bisialimi

An LGBT advocate and HIV activist, Alimi was the first person to ever come out as gay on Nigerian television. Alimi fled to the UK after an attempt on his life in Nigeria. His development work focuses on promoting human rights for gay Africans and the prevention of HIV/AIDS.

James Kassaga Arinaitwe, MA, MPH

School Partnerships Manager, Educate!, Uganda, @JamesArinaitwe

Arinaitwe’s advocacy and development work is focused on encouraging economic growth by fostering development and partnering with secondary schools to teach entrepreneurship and leadership skills to the next generation of Ugandans.

Yetnayet Asfaw Demessie, MD, MPH

Country Director, EngenderHealth, Ethiopia, @YetnayetAsfaw

As an advocate for education and the reproductive health rights of girls and women for nearly 20 years, Demessie works to encourage family planning, maternal and child health, and prevention of mother-to-child transmission of HIV.

Nafi Chinery, MA

Capacity Building Specialist, African Women’s Development Fund (AWDF), Ghana, @nafichinery

Chinery is passionate about promoting women’s rights in African countries and works with women-led organizations to train and advocate for their leadership and staff and their inclusion in decision making processes at different levels.

Anick Supplice Dupuy, MPH

Deputy Director, PSI Haiti, Haiti, @asdupuy

Through her work with Population Services International (PSI), Dupuy focuses on promoting HIV/AIDS prevention, malaria, family planning and maternal and child health through social marketing and communication programs.

Utibe Effiong, MD

MPH Candidate, University of Michigan, Nigeria, @UtibeEffiongMD

As an internist drawn to studying public health and epidemiology after seeing the impacts of Nigeria’s oil industry, Effiong is focused on both environmental drivers of health and chronic disease prevention, with a focus on diabetes as well as infectious diseases, which remain among the biggest health challenges in Africa.

Myshkin Ingawale, PhD

Cofounder, Biosense Technologies, India, @myshkinonline

Myshkin is driven to design and build innovative, disruptive healthcare technologies that improve care around the world. For example, his company Biosense created ToucHb, a needle-free blood hemoglobin testing device, and uChek, a mobile phone app and accessory that converts the smartphone into a medical-grade lab machine equivalent.

Sisonke Msimang

Writer, South Africa, @Sisonkemsimang

With a background in funding non-profit organizations fighting for democratic change in Africa, Msimang has become a powerful advocate for the better use of money and power on her continent. She also writes about sex.

Jacqueline Musiitwa, Esq.

Founder, Managing Partner, Hoja Law Group, Uganda/Zambia, @nubiancounsel

Musiitwa’s background in the law and policy has led her to focus on achieving sustainable development by advocating for investment, trade, good governance and rule of law, all to improve Africa’s standing in the world.

Ramadhani Abdallah Noor, MD, PhD

Research Associate, Harvard School of Public Health, Tanzania, @ranoortz

Noor was drawn to study public health and focus on vaccine development and dissemination after being overwhelmed by the number of patients he saw dying from preventable or treatable diseases and conditions. In addition to a focus on public health, he also advocates for food security and nutrition for maternal and child health in Africa.

Jensi Sartin

Director, Reef Check Indonesia Foundation, Indonesia, @jensisartin

Sartin witnessed the deforestation of rainforests in Borneo during his childhood, and it set him on a path focused on conservation. His advocacy is focused on the health of coral reefs and community-based approaches to manage them in the face of development.

Lindiwe Majele Sibanda, PhD, MSc

CEO, Head of Diplomatic Mission, Food Agriculture Natural Resources Policy Analysis Network, Zimbabwe, @lmsibanda

Sibanda’s work advocating for food and nutritional security covers 17 African countries and promotes sustainable agricultural development through innovation and entrepreneurship in agriculture.

Evans Wadongo

Founder, Executive Director, Sustainable Development For All, Kenya, @evanswadongo

Wadongo has been a leader by bringing both energy and economic development to rural communities in Kenya and Africa. He started with an initiative to use solar power to reduce the cycle of poverty for poor communities and is now advising young entrepreneurs and leaders on growing relevant innovations that tackle socio-economic problems for developing countries.

The Aspen Institute is an educational and policy studies organization based in Washington, DC. Its mission is to foster leadership based on enduring values and to provide a nonpartisan venue for dealing with critical issues. The Institute is based in Washington, DC; Aspen, Colorado; and on the Wye River on Maryland's Eastern Shore. It also has offices in New York City and an international network of partners. For more information, visit: www.aspeninstitute.org.

Using Evidence to Improve Policy and Programs

Mon, 04/07/2014 - 4:43pm

Leaders of social programs are under increasing pressure to do more with less. That's why many nonprofit leaders like you attend Using Evidence to Improve Policy and Programs, a transformative executive program at Harvard Kennedy School.

Here, you and your peers from around the world will be immersed in an inspiring, interactive environment led by renowned Harvard faculty. In just a few extraordinary days, you'll learn powerful evaluation strategies to assess and improve program effectiveness. Discover evidence that will shape policy and support new funding efforts. And leave with a lasting network of new colleagues. It's an experience that can't be duplicated. Hear Why.

Space is limited, so apply today.

Roundtable: How to Measure the Social Effects of CSR Strategies

Mon, 04/07/2014 - 1:42pm

The Centre for Sustainability and Excellence, devoted in updating the region on the newest international CSR news and tools, invites you to attend an insightful sustainability roundtable in New York on the 2nd of June 2014 (between 5:15pm and 7:15pm), straight after day 1 of the Advanced Certified Sustainability (CSR) Practitioner Training (IEMA Approved).

The Roundtable, with leading regional professionals and CSR experts, will focus on a crucial topic being a large business concern today "How can we measure the social effect of CSR strategies?" The goal is to go into depth about the challenges corporations confront, the investments in CSR actions and programs as well as the use of tools and international strategies like Social Return on Investment (SROI), which can form the framework that measure society coherent value.

The panel boasts a great experience across corporate social responsibility (CSR) and sustainability, including Nikos Avlonas, CEO and Founder of the Centre for Sustainability and Excellence, Bahar Gidwnani, CEO of CSRHub and NY area Angel Investor and Richard W. Parlier Jr., Sustainability Project Integration Specialist United States Postal Service.

If you are interested in CSR and SROI this is must-attend event.

CA Technologies Donates $200,000 to Global STEM Organizations

Mon, 04/07/2014 - 1:42pm

Today CA Technologies (NASDAQ: CA) announced a $200,000 contribution, which will be distributed to four global Science, Technology, Engineering and Math (STEM) organizations – Apps for Good, Girls Who Code, GVI Charitable Trust and Iracambi. This initiative is in partnership with the online donation marketplace, GlobalGiving. The donation marks a year-long celebration of the mainframe’s 50th anniversary and recognizes those who will drive IT innovation in the next 50 years.

“Investing in the future of IT is a top priority at CA Technologies, and that future is driven by the innovators and people who dream up the technology of tomorrow,” said Mike Madden, general manager, Mainframe, CA Technologies. “Our partnership with GlobalGiving enables us to support outstanding STEM organizations that seek to inspire next-gen technologists and creative thinkers who will shape the next wave of IT.”

The recipient organizations were selected on their dedication to STEM education. Iracambi’s Junior Scientist program transforms students into guardians of Brazil’s Atlantic Rainforest. Girls Who Code works to provide young women with the skills and resources to pursue opportunities in computing fields, both professional and academic. GVI Charitable Trust supports educational and training initiatives for disadvantaged students in Australia through the National Scholarship Program, and Apps for Good helps young people solve problems in their communities through mobile, social and web application development.

“This partnership with CA Technologies enhances the value GlobalGiving brings to these remarkable STEM organizations,” said Donna Callejon, Chief Business Officer of GlobalGiving. “The lack of qualified STEM talent is a concern in the United States and beyond. Solutions to many global challenges, including breaking cycles of poverty and increasing environmental sustainability, can be found in the seeds of STEM education, and we’re glad to have been part of a campaign that makes these disciplines more accessible to students across the globe.”

In addition to the STEM education campaign, CA Technologies is continuing its celebration of the 50th anniversary of the mainframe with a video series, which focuses on themes like “Technology of the Future” and “What today’s generation imagines IT to be.” A series of online panels is taking place featuring CA Technologies executives, educators and industry influencers discussing compelling IT trends powered by the mainframe, such as Internet of Things, Mobility, Big Data and more.

To learn more about how CA Technologies is celebrating the 50th anniversary of the mainframe or to participate in its mainframe initiatives, please visit www.mainframe50.com.  

About CA Technologies

CA Technologies (NASDAQ: CA) provides IT management solutions that help customers manage and secure complex IT environments to support agile business services. Organizations leverage CA Technologies software and SaaS solutions to accelerate innovation, transform infrastructure and secure data and identities, from the data center to the cloud. Learn more about CA Technologies at www.ca.com.

Follow CA Technologies

Legal Notices

Copyright © 2014 CA. All Rights Reserved. One CA Plaza, Islandia, N.Y. 11749. All other trademarks, trade names, service marks, and logos referenced herein belong to their respective companies.

 

 

 

Health Care Service Corporation and Community Partners Reach More Than Six Million Children Through Health and Wellness Initiatives

Mon, 04/07/2014 - 1:42pm

Health Care Service Corporation (HCSC), the nation’s largest customer-owned health insurer, collaborated with hundreds of community partners to improve the health and wellness of more than 6.7 million children in less than three years.

According to the company’s just-released Social Responsibility Report, which can be found online at www.hcsc2013srr.com, HCSC and local nonprofit organizations made significant progress reaching at-risk children by focusing community investments on nutrition, physical activity, disease prevention and management, and supporting safe environments. These four focus areas comprise the Healthy Kids, Healthy Families® initiative which was launched in 2011 as a three-year initiative to improve the health and wellness of at least one million children through community outreach and investments by Health Care Service Corporation and its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas.

“Thanks to the hard work of our community partners, we have been able to expand our efforts to help improve the health of the most vulnerable children and families in our local communities,” said David Sandor, vice president, public affairs, Health Care Service Corporation. "Our employees also played a pivotal role by volunteering more than 45,000 hours to community organizations that share our vision of helping children and their families have access to the resources they need to live healthy lives."

In just three years, with the help of more than 300 community partners, Healthy Kids, Healthy Families has far exceeded its initial goal. Due to the success of the initiative, HCSC will continue to expand the program beyond its initial three-year term to become part of the company’s ongoing commitment to support the health and wellness of the communities it serves. The program will also expand to include communities served by HCSC’s Blue Cross and Blue Shield of Montana health plan.

The company’s report also highlights progress across other components of its social responsibility including diversity and inclusion, sustainability and compliance.

Additional examples of HCSC’s collaboration with community organizations in 2013 include:

  • Be Covered – Partnering with more than 250 organizations to educate more than 3.6 million people on the basics of the Affordable Care Act.
  • KaBOOM! – Building 10 new playgrounds, adding shade structures to four existing playgrounds, and granting two Imagination Playgrounds to help bring exercise and safe play to more than 31,000 children.
  • The Care Van Program – Bringing mobile health care to uninsured children and families, including 150,000 free immunizations, blood pressure screenings and other services.

Additional highlights of the company’s contributions outlined in the 2013 report include:

  • Employees donating more than $930,000 to a variety of organizations through HCSC’s annual employee giving campaign.
  • Employees volunteering more than 45,000 hours in their local communities, an increase of 46 percent compared to 2012 and breaking previous records.
  • Saving more than 15 million gallons of water and recycling more than 2,000 tons of paper through the company’s ongoing sustainability efforts.
  • Receiving their 13th straight Compliance Best Practice Award.

As in the previous year, the 2013 report was produced digitally, reducing environmental impact and enabling a more dynamic presentation of community partnerships through videos and social media integration. Readers can instantly share and comment on a specific page of the report through Facebook, LinkedIn and Twitter or email the entire report to friends and colleagues.

About Health Care Service Corporation

Health Care Service Corporation is the country's largest customer-owned health insurer and fourth largest health insurer overall, with nearly 14 million members in its Blue Cross and Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma, Texas. A Mutual Legal Reserve Company, HCSC is an independent licensee of the Blue Cross and Blue Shield Association. For more information, please visit www.HCSC.com, visit our Facebook page or follow us at www.twitter.com/HCSC.

AccountAbility Honored by Game Changers 500

Mon, 04/07/2014 - 10:41am

AccountAbility was recently honored by Game Changers 500 for using business as a force for good. Game Changers 500 placed AccountAbility on its dynamic list that profiles the world’s top purpose-driven organizations, grouping the firm with companies such as Patagonia, Google, Kiva, Zappos, Whole Foods, Novo Nordisk and IDEO.

Describing itself as "an alternative to the Fortune 500 list," Game Changers 500 recognizes organizations for pioneering a new model of business that is focused on maximizing benefit to people and the planet rather than just maximizing profit. Rather than rank organizations from 1 to 500 based on revenue alone, the GC500 awards organizations up to 9 badges that represent best practices in using business to create positive change. The GC500 is entirely merit based to ensure the organizations that deserve the recognition are included, rather than just the companies wanting to pay for a PR boost.

AccountAbility was awarded badges related to innovation, scale of impact, mission-driven structure, employee empowerment, and a positive relationship with its stakeholders and society.

“Being acknowledged as a Game Changer is a source of honor and pride to our firm, and we feel privileged to be a part of it,” said Sunil Misser, AccountAbility’s Chief Executive Officer. “Our mission and the GC500’s mission are strongly aligned, and we are continuously improving to help our clients become Game Changers themselves.”

AccountAbility is a leading international organization focused on mainstreaming sustainability into business thinking and practice. Since 1995 we have been helping corporations, non-profits and governments embed ethical, environmental, social and governance accountability into their organizational DNA. Our unique value proposition brings together leading-edge research, widely-recognized standards and strategic advisory services to deliver practical solutions for our clients. With offices in New York, London, Zurich, Dubai and Riyadh, AccountAbility specializes in industry sectors such as Financial Services, Pharmaceuticals, Energy and Extractives, Telecommunications and Consumer Goods.

More information about the firm, its partners and services can be found on our site at www.accountability.org.

Chevron's Mockery of Justice

Mon, 04/07/2014 - 10:41am

Novartis and Malaria No More Provide Two Million Antimalarial Treatments to Children in Zambia

Mon, 04/07/2014 - 10:41am

Novartis announced today that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More’s Power of One campaign. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of Coartem® Dispersible have been funded through public donations and Novartis matched these with a further one million treatments. These antimalarials will reduce the disease burden in Zambia, which accounts for up to 40% of infant mortality in that country2.

“Although the incidence of malaria has decreased, the disease still kills a child every minute in Africa,” said Joseph Jimenez, CEO of Novartis. “Our commitment to Power of One reflects our company’s long-term efforts to fight malaria and Novartis remains dedicated to controlling and ultimately eliminating this deadly disease.”

Power of One is a global digital fundraising campaign that enables people around the world to help end child deaths from malaria, a preventable and treatable disease. This fatal disease has been recognized by the World Health Organization as a priority area of public health. This year’s World Health Day focuses on vector-borne diseases, and malaria is the most deadly1.

The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Donors are able to share information with their social networks and encourage friends to donate.

“One and a half million treatments are already on the ground in Zambia thanks to the Power of One campaign, with a further 500,000 anticipated in the coming weeks,” said Martin Edlund, CEO, Malaria No More. “Power of One is resonating with the general public, and their donations will help us ensure that children in Zambia will have access to the treatment they need.”

Novartis is supporting the campaign financially and has pledged to match up to 1 million treatments funded by the public every year through 2015. For more than a decade, the Novartis Malaria Initiative has worked to improve access to treatment, help communities deliver better healthcare and has invested in research and development into the next generation of antimalarials. Since 2009, Novartis has delivered over 600 million treatments, of which more than 200 million were treatments developed specifically for children, without profit to malaria-endemic countries. Never before have so many pediatric treatments been distributed in such a short timeframe to children suffering from malaria.

About Power of One
Malaria No More’s Power of One campaign offers the global public and corporations the opportunity to help end malaria deaths one dollar and one child at a time. Every dollar donated funds a full treatment course for a child diagnosed with malaria in Africa. Malaria No More is grateful for the support and contributions of Power of One partners: Novartis, Alere, the Zambian Government, 21st Century Fox, AGFUND, AHAlife.com, the Bill & Melinda Gates Foundation, Causes.com, Havas Worldwide, John Snow, Inc., Newman’s Own Foundation, PATH/MACEPA, Peace Corps, Time Warner, Twitter, the United States President’s Malaria Initiative, Venmo, West, and more. Additional information is available at www.Po1.org.

About the Novartis Malaria Initiative
The Novartis Malaria Initiative is one of the largest access-to-medicine programs in the healthcare industry. Moving forward, Novartis is committed to working towards malaria elimination by driving the development of next-generation antimalarials, with two new classes of drugs currently in clinical development. The most advanced compound is in Phase II clinical trials. For more information, please visit: www.malaria.novartis.com

Disclaimer
This press release contains expressed or implied forward-looking statements, including statements that can be identified by terminology such as “expects,” or similar expressions. Such forward-looking statements reflect the current views of the Group regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by such statements. These expectations could be affected by, among other things, risks and factors referred to in the Risk Factors section of Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update it in the future.

About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 136,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

References

1.      World Health Organization. World Health Day - 7 April 2014. http://www.who.int/campaigns/world-health-day/2014/event/en/ [last accessed February 2014]

2.      Malaria No More. Zambia. https://secure.malarianomore.org/po1#/pages/zambia [last accessed February 2014]

3.      Malaria No More. Power of One. https://secure.malarianomore.org/po1#/pages/about-power-of-one [last accessed February 2014]

Novartis Media Relations

Central media line : +41 61 324 2200

 

Eric Althoff

Novartis Global Media Relations

+41 61 324 7999 (direct)

+41 79 593 4202 (mobile)

eric.althoff@novartis.com

Nadine Schecker

Novartis Malaria Initiative Communications

+41 61 696 8633 (direct)

+41 79 682 1326 (mobile)

nadine.schecker@novartis.com

e-mail: media.relations@novartis.com

For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis

For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.

Novartis Investor Relations

Central phone:

+41 61 324 7944

 

 

Samir Shah

+41 61 324 7944

North America:

 

Pierre-Michel Bringer

+41 61 324 1065

Stephen Rubino

+1 862 778 8301

Thomas Hungerbuehler

+41 61 324 8425

Susan Donofrio

+1 862 778 9257

Isabella Zinck

+41 61 324 7188

 

 

 

 

 

 

e-mail: investor.relations@novartis.com

e-mail: investor.relations@novartis.com

 

 

Novartis et Malaria No More Fournissent Deux Millions de Traitements Antipaludiques aux Enfants de Zambie

Mon, 04/07/2014 - 4:39am

Novartis a annoncé aujourd'hui que deux millions de traitements de son antipaludique pédiatrique arrivent en Zambie grâce aux efforts actuels de la société, en collaboration avec la campagne Power of One de Malaria No More. La Zambie est le premier pays à bénéficier de cette campagne parrainée par Novartis. Un million de traitements Coartem® dispersible ont été financés par des dons publics, que Novartis a complétés par un million de traitements supplémentaires. Ces antipaludiques permettront à la Zambie d'endiguer le fléau de cette maladie qui représente jusqu'à 40 % de la mortalité infantile enregistrée dans ce pays2.

« Bien que les effets du paludisme aient diminué, cette maladie tue encore un enfant d'Afrique à chaque minute qui passe », a déclaré Joseph Jimenez, PDG de Novartis. « Notre engagement envers Power of One reflète les efforts à long terme que mène notre entreprise afin de lutter contre le paludisme. Novartis continue de se consacrer au contrôle et à l'éradication à terme de cette maladie mortelle. »

Power of One est une campagne de collecte de fonds ‘on line’ qui permet aux citoyens du monde entier de contribuer à faire cesser la mort des enfants atteints de paludisme, une maladie évitable et curable. Cette maladie mortelle a été reconnue par l'Organisation Mondiale de la Santé comme un domaine prioritaire de santé publique. Cette année, la Journée mondiale de la santé est axée sur les maladies à transmission vectorielle, parmi lesquelles le paludisme est la plus meurtrière1.

Lancée publiquement en septembre 2013, la campagne Power of One utilise les réseaux sociaux, les technologies mobiles et l'e-commerce afin de permettre au grand public de financer des traitements pour les enfants de Zambie. Les donateurs peuvent partager des informations sur leurs réseaux sociaux et encourager leurs amis à faire un don.

« Un million et demi de traitements ont déjà été livrés à la Zambie grâce à la puissance de la campagne Power of One et 500 000 traitements supplémentaires sont attendus dans les prochaines semaines », a ajouté Martin Edlund, PDG de Malaria No More. « Power of One trouve un écho auprès du grand public, dont les dons nous permettront de veiller à ce que les enfants de Zambie aient accès au traitement dont ils ont besoin. »

Novartis soutient financièrement cette campagne et a promis d'ajouter jusqu'à 1 million de traitements à ceux financés par le grand public, et ce chaque année jusqu'en 2015. Pendant plus d'une décennie, le programme Novartis Malaria Initiative a contribué à améliorer l'accès au traitement, aidé les communautés à prodiguer de meilleurs soins et a investi dans la recherche et le développement de la prochaine génération d'antipaludiques. Depuis 2009, Novartis a livré plus de 600 millions de traitements, dont plus de 200 millions ont été élaborés spécifiquement pour les enfants, sans tirer de profit de la part des régions d'endémie palustre. C'est la première fois qu'autant de traitements pédiatriques ont été distribués en si peu de temps pour aider les enfants atteints de paludisme.

À propos de Power of One  
La campagne Power of One de Malaria No More offre au grand public et aux entreprises du monde entier l'occasion d'aider à faire cesser les morts liées au paludisme, par l'intermédiaire de dons d'un dollar par enfant. Chaque dollar offert permet de financer un traitement complet pour un enfant d'Afrique atteint de paludisme. Malaria No More tient à remercier les partenaires du programme Power of One pour leur soutien et leur contribution : Novartis, Alere, le Gouvernement de Zambie, 21st Century Fox, AGFUND, AHAlife.com, la fondation Bill & Melinda Gates, Causes.com, Havas Worldwide, John Snow, Inc., la fondation privée Newman, PATH/MACEPA, Peace Corps, Time Warner, Twitter, le programme Malaria Initiative du président des États-Unis, Venmo, West et bien d'autres. Des renseignements complémentaires sont disponibles sur le site www.Po1.org.

À propos du programme Novartis Malaria Initiative 
Le programme Novartis Malaria Initiative est l'un des programmes d'accès aux médicaments les plus importants dans le secteur des soins de santé. Concernant l'avenir, la société Novartis s'est engagée à contribuer à l'éradication du paludisme en menant l'élaboration de la prochaine génération d'antipaludiques, qui comprend deux nouvelles classes de médicaments en cours de développement. Le composé le plus avancé fait actuellement l'objet d'essais cliniques de phase II. Pour tout renseignement complémentaire, veuillez consulter le site www.malaria.novartis.com

Avertissement
Ce communiqué de presse contient des énoncés prospectifs explicites ou implicites, et notamment des énoncés qui peuvent être identifiés par des termes tels que « s'attend à » ou des expressions similaires. Ces énoncés prospectifs reflètent les opinions actuelles du groupe au sujet des événements futurs et impliquent des risques, des incertitudes et d'autres facteurs connus et inconnus qui pourraient amener les résultats réels à différer sensiblement des résultats futurs exprimés ou sous-entendus par de tels énoncés. Ces prévisions peuvent être affectées, entre autres, par des risques et des facteurs décrits dans la section Facteurs de risque du formulaire 20-F actuel de Novartis AG, déposé auprès de la Securities and Exchange Commission des États-Unis. Dans ce communiqué de presse, Novartis fournit des renseignements valables à la date présente et n'assume aucune obligation de les mettre à jour à l'avenir.

À propos de Novartis 
Novartis propose des solutions thérapeutiques innovantes qui répondent aux besoins en constante évolution des patients et des sociétés. Basée à Bâle, en Suisse, la société Novartis dispose d'un portefeuille diversifié lui permettant de répondre au mieux à ces besoins : médicaments innovants, soins ophtalmologiques, médicaments génériques peu coûteux, vaccins préventifs et outils de diagnostic, médicaments en vente libre et produits de santé animale. Novartis est la seule entreprise mondiale occupant une position de leader dans ces domaines. En 2013, le groupe a enregistré un chiffre d'affaires de 57,9 milliards USD, tandis que l'activité R&D au sein du groupe a été financée à hauteur d'environ 9,9 milliards USD (9,6 milliards USD hors dépréciations et amortissements). Les sociétés du groupe Novartis emploient près de 136 000 personnes à plein temps (ou emploi équivalent) et opèrent dans plus de 140 pays à travers le monde. Pour tout complément d'information, veuillez consulter le site http://www.novartis.com.

La société Novartis est active sur Twitter. Inscrivez-vous pour suivre @Novartis à l'adresse http://twitter.com/novartis.

 Références

1.      Organisation mondiale de la santé. Journée mondiale de la santé - 7 avril 2014. http://www.who.int/campaigns/world-health-day/2014/event/en/ [dernier accès : février 2014]

2.      Malaria No More. Zambie. https://secure.malarianomore.org/po1#/pages/zambia [dernier accès : février 2014]

3.      Malaria No More. Power of One. https://secure.malarianomore.org/po1#/pages/about-power-of-one [dernier accès : février 2014]

Relations de Novartis avec les médias

Ligne centrale pour les médias : +41 61 324 2200 

Eric Althoff 

Relations internationales de Novartis avec les médias

+41 61 324 7999 (ligne directe)

+41 79 593 4202 (portable)

eric.althoff@novartis.com

Nadine Schecker  

Communications du programme Novartis Malaria Initiative

+41 61 696 8633 (ligne directe)

+41 79 682 1326 (portable)

nadine.schecker@novartis.com

E-mail : media.relations@novartis.com

Des contenus multimédias de Novartis sont disponibles sur le site Internet www.thenewsmarket.com/Novartis
Pour toute question concernant le site ou pour prendre connaissance des conditions d'inscription, veuillez contacter : journalisthelp@thenewsmarket.com.

Relations de Novartis avec les investisseurs 

Central téléphonique : 

+41 61 324 7944

 

 

Samir Shah

+41 61 324 7944

Amérique du Nord :

 

Pierre-Michel Bringer

+41 61 324 1065

Stephen Rubino

+1 862 778 8301

Thomas Hungerbuehler

+41 61 324 8425

Susan Donofrio

+1 862 778 9257

Isabella Zinck

+41 61 324 7188

 

 

 

 

 

 

E-mail : investor.relations@novartis.com

E-mail : investor.relations@novartis.com

 

 

Novartis and Malaria No More provide two million antimalarial treatments to children in Zambia

Mon, 04/07/2014 - 4:39am

Novartis announced today that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More’s Power of One campaign. Zambia is the first beneficiary country of this campaign sponsored by Novartis. One million treatments of Coartem® Dispersible have been funded through public donations and Novartis matched these with a further one million treatments. These antimalarials will reduce the disease burden in Zambia, which accounts for up to 40% of infant mortality in that country2.

“Although the incidence of malaria has decreased, the disease still kills a child every minute in Africa,” said Joseph Jimenez, CEO of Novartis. “Our commitment to Power of One reflects our company’s long-term efforts to fight malaria and Novartis remains dedicated to controlling and ultimately eliminating this deadly disease.”

Power of One is a global digital fundraising campaign that enables people around the world to help end child deaths from malaria, a preventable and treatable disease. This fatal disease has been recognized by the World Health Organization as a priority area of public health. This year’s World Health Day focuses on vector-borne diseases, and malaria is the most deadly1.

The campaign, which launched to the public in September 2013, uses social, mobile, and e-commerce technologies, enabling the public to purchase treatments for children in Zambia. Donors are able to share information with their social networks and encourage friends to donate.

“One and a half million treatments are already on the ground in Zambia thanks to the Power of One campaign, with a further 500,000 anticipated in the coming weeks,” said Martin Edlund, CEO, Malaria No More. “Power of One is resonating with the general public, and their donations will help us ensure that children in Zambia will have access to the treatment they need.”

Novartis is supporting the campaign financially and has pledged to match up to 1 million treatments funded by the public every year through 2015. For more than a decade, the Novartis Malaria Initiative has worked to improve access to treatment, help communities deliver better healthcare and has invested in research and development into the next generation of antimalarials. Since 2009, Novartis has delivered over 600 million treatments, of which more than 200 million were treatments developed specifically for children, without profit to malaria-endemic countries. Never before have so many pediatric treatments been distributed in such a short timeframe to children suffering from malaria.

About Power of One
Malaria No More’s Power of One campaign offers the global public and corporations the opportunity to help end malaria deaths one dollar and one child at a time. Every dollar donated funds a full treatment course for a child diagnosed with malaria in Africa. Malaria No More is grateful for the support and contributions of Power of One partners: Novartis, Alere, the Zambian Government, 21st Century Fox, AGFUND, AHAlife.com, the Bill & Melinda Gates Foundation, Causes.com, Havas Worldwide, John Snow, Inc., Newman’s Own Foundation, PATH/MACEPA, Peace Corps, Time Warner, Twitter, the United States President’s Malaria Initiative, Venmo, West, and more. Additional information is available at www.Po1.org.

About the Novartis Malaria Initiative
The Novartis Malaria Initiative is one of the largest access-to-medicine programs in the healthcare industry. Moving forward, Novartis is committed to working towards malaria elimination by driving the development of next-generation antimalarials, with two new classes of drugs currently in clinical development. The most advanced compound is in Phase II clinical trials. For more information, please visit: www.malaria.novartis.com

Disclaimer
This press release contains expressed or implied forward-looking statements, including statements that can be identified by terminology such as “expects,” or similar expressions. Such forward-looking statements reflect the current views of the Group regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by such statements. These expectations could be affected by, among other things, risks and factors referred to in the Risk Factors section of Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update it in the future.

About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. Novartis is the only global company with leading positions in these areas. In 2013, the Group achieved net sales of USD 57.9 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 136,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

References

1.      World Health Organization. World Health Day - 7 April 2014. http://www.who.int/campaigns/world-health-day/2014/event/en/ [last accessed February 2014]

2.      Malaria No More. Zambia. https://secure.malarianomore.org/po1#/pages/zambia [last accessed February 2014]

3.      Malaria No More. Power of One. https://secure.malarianomore.org/po1#/pages/about-power-of-one [last accessed February 2014]

Novartis Media Relations

Central media line : +41 61 324 2200

 

Eric Althoff

Novartis Global Media Relations

+41 61 324 7999 (direct)

+41 79 593 4202 (mobile)

eric.althoff@novartis.com

Nadine Schecker

Novartis Malaria Initiative Communications

+41 61 696 8633 (direct)

+41 79 682 1326 (mobile)

nadine.schecker@novartis.com

e-mail: media.relations@novartis.com

For Novartis multimedia content, please visit www.thenewsmarket.com/Novartis

For questions about the site or required registration, please contact: journalisthelp@thenewsmarket.com.

Novartis Investor Relations

Central phone:

+41 61 324 7944

 

 

Samir Shah

+41 61 324 7944

North America:

 

Pierre-Michel Bringer

+41 61 324 1065

Stephen Rubino

+1 862 778 8301

Thomas Hungerbuehler

+41 61 324 8425

Susan Donofrio

+1 862 778 9257

Isabella Zinck

+41 61 324 7188

 

 

 

 

 

 

e-mail: investor.relations@novartis.com

e-mail: investor.relations@novartis.com

 

 

Novartis und Malaria No More liefern zwei Millionen Antimalaria-Behandlungseinheiten für Kinder nach Sambia

Mon, 04/07/2014 - 4:39am

Novartis hat heute angekündigt, dass durch die fortlaufende Zusammenarbeit mit der «Power of One»-Kampagne von Malaria No More zwei Millionen Behandlungseinheiten ihres pädiatrischen Malariamedikaments in Sambia bereitstehen werden. Sambia ist das erste Land, das von der von Novartis geförderten Kampagne profitiert. Eine Million Behandlungseinheiten von Coartem® Dispersible wurden durch Spenden aus der Öffentlichkeit finanziert; Novartis verdoppelte diese Menge durch eine eigene Spende von einer weiteren Million Behandlungseinheiten. Die Antimalaria-Medikamente werden die Malariabelastung in Sambia reduzieren; die Krankheit ist in dem Land derzeit für bis zu 40% der Kindersterblichkeit verantwortlich2.

«Zwar ist die Malaria auf dem Rückzug, doch stirbt in Afrika immer noch jede Minute ein Kind an der Krankheit», erklärt Joseph Jimenez, CEO von Novartis. «Unsere Unterstützung für Power of One spiegelt unser langfristiges Engagement im Kampf gegen die Malaria wider. Novartis bleibt dem Ziel der Kontrolle und letztendlichen Eliminierung dieser tödlichen Krankheit verpflichtet.»

Power of One ist eine weltweite digitale Spendenkampagne, die es Menschen in aller Welt ermöglicht, zur Eliminierung von Todesfällen bei Kindern durch Malaria, einer vermeidbaren und behandelbaren Krankheit,  beizutragen. Die tödliche Krankheit wurde von der Weltgesundheitsorganisation zur Priorität des öffentlichen Gesundheitswesens erklärt. Der diesjährige Weltgesundheitstages hat vektorübertragene Krankheiten zum Thema; die Malaria ist die tödlichste dieser Erkrankungen1.

Die im September 2013 gestartete Kampagne bietet der Öffentlichkeit mit Hilfe von Sozial-, Mobil‑ und E-Commerce-Technologien die Möglichkeit, Malariamedikamente für Kinder in Sambia zu kaufen. Die Spender können die Informationen in ihren Netzwerken weitergeben und so Freunde für weitere Spenden zu gewinnen.

«Eineinhalb Millionen Behandlungseinheiten befinden sich dank der ‹Power of One›-Kampagne bereits in Sambia vor Ort und weitere 500.000 Einheiten werden in den kommenden Wochen erwartet», so Martin Edlund, CEO von Malaria No More. «Power of One hat grosse Resonanz in der Öffentlichkeit gefunden. Die Spenden helfen uns sicherzustellen, dass Kinder in Sambia Zugang zu den benötigten Medikamenten haben.»

Novartis unterstützt die Kampagne finanziell und hat versprochen, die Spenden aus der Öffentlichkeit bis 2015 jährlich durch eigene Spenden in gleicher Höhe – bis zu einer Million Behandlungseinheiten – zu verdoppeln. Die Malaria-Initiative von Novartis arbeitet seit über einem Jahrzehnt daran, den Behandlungszugang und die Gesundheitsversorgung in den Gemeinden zu verbessern, und investiert in die Erforschung und Entwicklung der nächsten Generation von Malariamedikamenten. Seit 2009 hat Novartis über 600 Millionen Behandlungseinheiten – davon mehr als 200 Millionen speziell für Kinder entwickelte Malariamedikamente – zum Selbstkostenpreis an Patienten in Ländern mit endemischer Malaria geliefert. Nie zuvor wurden so viele pädiatrische Behandlungseinheiten in so kurzer Zeit bereitgestellt, um an Malaria erkrankten Kindern zu helfen.

Über Power of One
Die «Power of One»-Kampagne von Malaria No More gibt der Weltöffentlichkeit und grossen Unternehmen Gelegenheit, den Kampf gegen die tödliche Krankheit Malaria zu unterstützen, wobei jeder Dollar zählt und ein Kind rettet. Jeder gespendete Dollar finanziert einen vollen Behandlungszyklus für ein Kind mit diagnostizierter Malaria in Afrika. Malaria No More ist den folgenden «Power of One»-Partnern dankbar für ihre Unterstützung: Novartis, Alere, der Regierung von Sambia, 21st Century Fox, AGFUND, AHAlife.com, der Bill & Melinda Gates Stiftung, Causes.com, Havas Worldwide, John Snow Inc., Newman’s Own Foundation, PATH/MACEPA, dem Friedenscorps, Time Warner, Twitter, der US President’s Malaria Initiative, Venmo, West u.a. Weitere Informationen finden Sie im Internet unter www.Po1.org.

Über die Malaria-Initiative von Novartis
Die Malaria-Initiative von Novartis ist eines der grössten Arzneimittelzugangsprogramme der Gesundheitsbranche. In der Zukunft will Novartis durch die nächste Generation von Malariamedikamenten weiter zur Eliminierung der Krankheit beitragen. Derzeit befinden sich zwei neue Klassen von Malariapräparaten in der klinischen Entwicklung. Mit dem am weitesten fortgeschrittenen Wirkstoff werden derzeit klinische Phase-II-Studien durchgeführt. Weitere Informationen finden Sie im Internet unter www.malaria.novartis.com

Disclaimer
Die vorstehende Mitteilung enthält zukunftsgerichtete Aussagen, die daran erkennbar sind, dass sie Begriffe wie „erwartet“ oder ähnliche Wörter beinhalten. Die von solchen zukunftsgerichteten Aussagen behandelten Sachverhalte spiegeln die derzeitige Ansicht des Konzerns hinsichtlich zukünftiger Ereignisse wider. Sie unterliegen bekannten und unbekannten Risiken, Ungewissheiten und anderen Faktoren, die dazu führen können, dass die tatsächlichen Ergebnisse wesentlich von zukünftigen Ergebnissen abweichen, die in diesen zukunftsbezogenen Aussagen beschrieben werden oder impliziert sind. Insbesondere könnten diese Erwartungen unter anderem aufgrund der Risiken und Faktoren, die im aktuellen, bei der U.S. Securities and Exchange Commission eingereichten „Form 20-F“ erwähnt werden, nicht erfüllt werden. Die in dieser Medienmitteilung bereitgestellten Informationen befinden sich auf dem aktuellen Stand zum Zeitpunkt der Veröffentlichung. Novartis ist nicht verpflichtet, sie zu einem künftigen Zeitpunkt zu aktualisieren.

Über Novartis
Novartis bietet innovative medizinische Lösungen an, um damit auf die sich verändernden Bedürfnisse von Patienten und Gesellschaften einzugehen. Novartis hat ihren Sitz in Basel (Schweiz) und verfügt über ein diversifiziertes Portfolio, um diese Bedürfnisse so gut wie möglich zu erfüllen – mit innovativen Arzneimitteln, ophthalmologischen Produkten, kostengünstigen generischen Medikamenten, präventiven Impfstoffen und Diagnostika, rezeptfreien Medikamenten und tiermedizinischen Produkten. Novartis ist das einzige global tätige Unternehmen mit führenden Positionen in diesen Bereichen. Im Jahr 2013 erzielte der Konzern einen Nettoumsatz von USD 57,9 Milliarden und wies Kosten für Forschung und Entwicklung in Höhe von rund USD 9,9 Milliarden (USD 9,6 Milliarden unter Ausschluss von Wertminderungen und Abschreibungen) aus. Die Novartis Konzerngesellschaften beschäftigen rund 136.000 Mitarbeiterinnen und Mitarbeiter (Vollzeitstellenäquivalente) in über 140 Ländern weltweit. Weitere Informationen finden Sie im Internet unter http://www.novartis.com.

Novartis ist auf Twitter. Melden Sie sich an und verfolgen Sie @Novartis unter http://twitter.com/novartis.

Verweise

1.      Weltgesundheitsorganisation. Weltgesundheitstag – 7. April 2014. http://www.who.int/campaigns/world-health-day/2014/event/en/ [zuletzt abgerufen im Februar 2014]

2.      Malaria No More. Sambia. https://secure.malarianomore.org/po1#/pages/zambia [zuletzt abgerufen im Februar 2014]

3.      Malaria No More. Power of One. https://secure.malarianomore.org/po1#/pages/about-power-of-one [zuletzt abgerufen im Februar 2014]

Novartis Media Relations

Zentrale Anlaufstelle für Medien:

 

+41 61 324 2200 

Eric Althoff 

Novartis Global Media Relations

+41 61 324 7999 (direkt)

+41 79 593 4202 (mobil)

eric.althoff@novartis.com

Nadine Schecker  

Novartis Malaria Initiative Communications

+41 61 696 8633 (direkt)

+41 79 682 1326 (mobil)

nadine.schecker@novartis.com

E-Mail: media.relations@novartis.com

Multimedia-Inhalte von Novartis stehen auf www.thenewsmarket.com/Novartis.
Bei Fragen zu dieser Seite oder zur Anforderung der erforderlichen Registrierungsdaten kontaktieren Sie bitte journalisthelp@thenewsmarket.com.

Novartis Investor Relations

Zentrale: 

+41 61 324 7944

 

 

Samir Shah

+41 61 324 7944

Nordamerika:

 

Pierre-Michel Bringer

+41 61 324 1065

Stephen Rubino

+1 862 778 8301

Thomas Hungerbühler

+41 61 324 8425

Susan Donofrio

+1 862 778 9257

Isabella Zinck

+41 61 324 7188

 

 

 

 

 

 

E-Mail: investor.relations@novartis.com

E-Mail: investor.relations@novartis.com

 

 

Eco Heroes Save The Climate

Fri, 04/04/2014 - 4:07pm

Hippo Works, the Venice Beach-based eco animation studio, is online launching a half-hour cartoon musical Eco Heroes Save The Climate this Earth Day, April 22 [click for trailer].

Whole Foods sponsored the film’s earlier DVD premiere at a solar-powered theater in Los Angeles. Since then NASA has been screening the film for educational outreach to kids, and it’s now traveling to Manhattan’s Pier 94 on April 26-27 as part of Green America and Global Exchange’s nationally touring Green Festivals.

Hippo Works founder, cartoonist Denis Thomopoulos, created this film after receiving requests from fans of his annual Earth Day cartoons for a more in-depth story on one of the most important issues of our time.

Along with the film’s arrival in New York comes another one of Denis’s eco creations – a Faberge egg he painted that depicts migrating Asian elephants at the request of The Elephant Family, a nonprofit devoted to protecting elephants’ migratory corridors from encroaching development. The egg can be found at the Brooklyn Children’s Museum April 1-17th, then at Rockefeller Center April 18 prior to its sale at Sotheby’s to raise funds for the elephants.

Denis’s mission is a big one – to create cartoons that entertain and inspire kids to care for our Earth. As he writes on hippoworks.com, “we stand on what we stand for.”

Of the Eco Heroes movie, actor and environmentalist Ed Begley Jr. says
“Your kids will love this fun and charming film and, better still, be inspired by it. Eco Heroes Save The Climate shows how our actions affect the planet – all in a great adventure story.” And with each purchase, Hippo Works buys 1000 sq. ft. of jungle through Conservation International to help kids be eco heroes too.

April 2014 Events

April 1-17th:         Denis’s Faberge egg at the Brooklyn Children’s Museum                     

                               (as part of The Big Egg Hunt citywide)

April 18-25th:       Egg at Rockefeller Center

April 22nd:            Earth Day online launch of Eco Heroes Save The Climate

                                and sale of Denis’s egg at Sotheby’s

April 26-27th:        Film screenings at Green Festival, Pier 94 in Manhattan

About Denis and Hippo Works
Denis Thomopoulos turned a Masters degree from Oxford into an early career working for world-renowned filmmakers such as David Puttnam and Irwin Winkler – only to realize his heart was in cartooning and the environment. So Denis took a red hippo named Simon he’d drawn for a best-selling t-shirt in college and made him the star of his new eco animation company, Hippo Works. Denis has syndicated and licensed Simon along with a host of animal characters to companies such as AOL, National Geographic Kids, Paramount Vantage, SWAPE (Soil Water Air Protection Enterprise), Care2.com, Con Edison, and Clear Channel, among others. His characters also appear on organic products at Whole Foods in Southern California with purchases saving square feet of jungle through Conservation International.

For queries or to see the film for review purposes, please contact Amy Thomases.

Media Contact:
Amy Thomases
917 796 3589
amythomases@gmail.com

Want to be an Eco Hero too?
See how just by embedding the trailer

Pages